Evidence map›Paper›PMID 37240649›Full record

ArticleJournal of clinical medicine2023

Do Exophytic and Endophytic Patterns in Borderline Ovarian Tumors Have Different Prognostic Implications? A Large Multicentric Experience.

Vito Andrea Capozzi, Elisa Scarpelli, Luciano Monfardini, Vincenzo Dario Mandato, Carla Merisio, Stefano Uccella, Giulio Sozzi, Marcello Ceccaroni, Vito Chiantera, Giovanna Giordano and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 1 country.

Vito Andrea CapozziDepartment of Medicine and Surgery, University Hospital of Parma, 43125 Parma, Italy.
Elisa ScarpelliDepartment of Medicine and Surgery, University Hospital of Parma, 43125 Parma, Italy.
Luciano MonfardiniDepartment of Medicine and Surgery, University Hospital of Parma, 43125 Parma, Italy.
Vincenzo Dario MandatoUnit of Obstetrics and Gynecology, Azienda USL-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy.
Carla MerisioDepartment of Medicine and Surgery, University Hospital of Parma, 43125 Parma, Italy.
Stefano UccellaDepartment of Obstetrics and Gynecology, AOUI Verona, University of Verona, 37126 Verona, Italy.
Giulio SozziDepartment of Gynecologic Oncology, University of Palermo, 90127 Palermo, Italy.ORCID 0000-0001-5847-8822
Marcello CeccaroniDepartment of Obstetrics and Gynaecology, Gynaecologic Oncology, and Minimally Invasive Pelvic Surgery, International School of Surgical Anatomy, Sacred Heart Hospital, 37024 Negrar, Italy.
Vito ChianteraDepartment of Gynecologic Oncology, University of Palermo, 90127 Palermo, Italy.
Giovanna GiordanoPathology Unit, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.ORCID 0000-0003-4357-1287
Luigi Della CorteDepartment of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-0584-2181
Carmine ConteDepartment of General Surgery and Medical-Surgical Specialties, Institute of Obstetrics and Gynecology, A.O.U. Policlinico Rodolico, San Marco, University of Catania, 95125 Catania, Italy.ORCID 0000-0002-1993-4562
Stefano CianciUnit of Gynecology and Obstetrics, Department of Human Pathology of Adult and Childhood "G. Barresi", University of Messina, 98121 Messina, Italy.
Tullio GhiDepartment of Medicine and Surgery, University Hospital of Parma, 43125 Parma, Italy.
Roberto BerrettaDepartment of Medicine and Surgery, University Hospital of Parma, 43125 Parma, Italy.
University of Parma · ITUniversity of Palermo · ITAzienda Sanitaria Unità Locale di Reggio Emilia · ITUniversity of Catania · ITUniversity of Messina · ITUniversity of Naples Federico II · ITUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Borderline ovarian tumor (BOT) accounts for 15-20% of all epithelial ovarian tumors. Concerns have arisen about the clinical and prognostic implications of BOT with exophytic growth patterns. We retrospectively reviewed all cases of BOT patients surgically treated from 2015 to 2020. Patients were divided into an endophytic pattern (with intracystic tumor growth and intact ovarian capsule) and an exophytic pattern (with tumor growth outside the ovarian capsule) group. Among the 254 patients recruited, 229 met the inclusion criteria, and of these, 169 (73.8%) belonged to the endophytic group. The endophytic group showed more commonly an early FIGO stage than the exophytic group (100.0% vs. 66.7%,

Indexed as

borderline ovarian tumorBOTendophytic patternexophytic patterntumor growth

Identifiers

PMID37240649
PMCPMC10219359
OpenAlexW4377104638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.